The activated coagulation Factor X (FXa) stimulating agents may be used in the treatment of hemorrhaging in a subject. Compounds and combinations are described which are particularly useful for the topical treatment of hemorrhaging in a healthy subject or in a subject with hemorrhagic diathesis.